Your browser doesn't support javascript.
loading
Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer.
Grabowski, Jacek P; Martinez Vila, Clara; Richter, Rolf; Taube, Eliane; Plett, Helmut; Braicu, Elena; Sehouli, Jalid.
  • Grabowski JP; Department of Gynecology with Center of Oncological Surgery, Virchow Campus Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany jacek.grabowski@charite.de.
  • Martinez Vila C; Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Richter R; Department of Gynecology with Center of Oncological Surgery, Virchow Campus Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Taube E; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Plett H; Department of Gynecology with Center of Oncological Surgery, Virchow Campus Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Braicu E; Department of Gynecology and Gynecologic Oncology, Kliniken-Essen-Mitte, Essen, Germany.
  • Sehouli J; Department of Gynecology with Center of Oncological Surgery, Virchow Campus Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany.
Int J Gynecol Cancer ; 30(4): 498-503, 2020 04.
Article en En | MEDLINE | ID: mdl-31996397

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso / Antígeno Ki-67 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso / Antígeno Ki-67 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article